Phase I study of MG98, an oligonucleotide antisense inhibitor of human DNA methyltransferase 1, given as a 7-day infusion in patients with advanced solid tumors. (Q39985716)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of MG98, an oligonucleotide antisense inhibitor of human DNA methyltransferase 1, given as a 7-day infusion in patients with advanced solid tumors. |
scientific article |
Statements
Phase I study of MG98, an oligonucleotide antisense inhibitor of human DNA methyltransferase 1, given as a 7-day infusion in patients with advanced solid tumors (English)
Ruth Plummer
Laura Vidal
Melanie Griffin
Mark Lesley
Sally Coulthard
Julieann Sludden
Lillian L Siu
Eric X Chen
Amit M Oza
Gregory K Reid
A Robert McLeod
Jeffrey M Besterman
Chooi Lee
Ian Judson